Susquehanna International Group’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-22,700
Closed -$124K 12167
2024
Q2
$124K Buy
22,700
+3,000
+15% +$18.9K ﹤0.01% 10872
2024
Q1
$159K Buy
19,700
+7,000
+55% +$61.9K ﹤0.01% 10845
2023
Q4
$126K Buy
+12,700
New +$99.7K ﹤0.01% 11135
2023
Q2
Sell
-10,000
Closed -$103K 12248
2023
Q1
$103K Sell
10,000
-4,200
-30% -$49.5K ﹤0.01% 11269
2022
Q4
$156K Buy
14,200
+3,200
+29% +$41.1K ﹤0.01% 10451
2022
Q3
$171K Buy
11,000
+1,300
+13% +$28.6K ﹤0.01% 11066
2022
Q2
$222K Buy
+9,700
New +$207K ﹤0.01% 10369

Other funds holding DH

Susquehanna International Group's DH Position: Q1 2026 in Review

Susquehanna International Group reduced its Definitive Healthcare (DH) stake by 70% in Q1 2026, selling an estimated $54.5K and leaving 13,635 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #12884.

Susquehanna International Group first reported a position in DH in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.08M in Q2 2023. 119 funds tracked by Wall St. Rank hold DH as of Q1 2026.

  • Susquehanna International Group held 13,635 shares of Definitive Healthcare worth $16.8K as of Q1 2026.
  • Susquehanna International Group sold 31,355 Definitive Healthcare shares in Q1 2026, an estimated $54.5K.
  • Definitive Healthcare made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12884 holding.
  • Susquehanna International Group first reported a position in Definitive Healthcare in Q3 2021 and has held it in 14 quarters since.
  • Susquehanna International Group's Definitive Healthcare position peaked at $1.08M in Q2 2023.
  • 119 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.